【结 构 式】 |
【分子编号】14647 【品名】5-methoxy-3,4-dihydro-2(1H)-naphthalenone 【CA登记号】32940-15-1 |
【 分 子 式 】C11H12O2 【 分 子 量 】176.21508 【元素组成】C 74.98% H 6.86% O 18.16% |
合成路线1
该中间体在本合成路线中的序号:(I)The reaction of 5-methoxy-2-tetralone (I) with benzenethiosulfonic acid S-phenyl ester and sodium acetate in methanol gives 1,1-bis(phenylsulfanyl)-2-tetralone (II), which is condensed with 2-(bromomethyl)acrylic acid tert-butyl ester (III) by means of n-BuLi and diisopropylamine (DIA) in THF to yield the acrylic acid derivative (IV). Desulfurization of (IV) with Al/Hg in THF/water affords compound (V), which is treated with O-methylhydroxylamine and Na2HPO4 in methanol, providing the methoxyimino compound (VI). The reduction of (VI) with Zn/HOAc provides the methoxyamino compound (VII). The cyclization of (VII) by means of potassium hydrogen phosphate gives 1,6-dimethoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylic acid tert-butyl ester as a diastereomeric mixture that is separated by chromatography to furnish the desired diastereomer (VIII). Hydrolysis of the tert-butoxy ester group of (VIII) by means of TFA yields the carboxylic acid (IX), which is treated with diazomethane to afford the methyl ester (X). Selective demethoxylation of (X) with Zn/HOAc provides the octahydrobenzoquinoline (XI).
【1】 Nordmann, R.; Petcher, T.J.; Octahydrobenzo[g]quinolines: Potent dopamine agonists which show the relationship between ergolines and apomorphine. J Med Chem 1985, 28, 3, 367. |
【2】 Petcher, T.J.; Nordmann, R. (Novartis AG); Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivs.. EP 0077754; ES 8606281; ES 8706120 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(II) | 44372 | 5-methoxy-1,1-bis(phenylsulfanyl)-3,4-dihydro-2(1H)-naphthalenone | C23H20O2S2 | 详情 | 详情 | |
(III) | 44373 | tert-butyl 2-(bromomethyl)acrylate | C8H13BrO2 | 详情 | 详情 | |
(IV) | 44374 | tert-butyl 2-[[8-methoxy-3-oxo-4,4-bis(phenylsulfanyl)-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]acrylate | C31H32O4S2 | 详情 | 详情 | |
(V) | 44375 | tert-butyl 2-[(8-methoxy-3-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)methyl]acrylate | C19H24O4 | 详情 | 详情 | |
(VI) | 44376 | tert-butyl 2-[[8-methoxy-3-(methoxyimino)-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]acrylate | C20H27NO4 | 详情 | 详情 | |
(VII) | 44377 | tert-butyl 2-[[8-methoxy-3-(methoxyamino)-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]acrylate | C20H29NO4 | 详情 | 详情 | |
(VIII) | 44378 | tert-butyl (3S,4aR,10aR)-1,6-dimethoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylate | C20H29NO4 | 详情 | 详情 | |
(IX) | 44379 | (3S,4aR,10aR)-1,6-dimethoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylic acid | C16H21NO4 | 详情 | 详情 | |
(X) | 44380 | methyl (3S,4aR,10aR)-1,6-dimethoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylate | C17H23NO4 | 详情 | 详情 | |
(XI) | 44381 | methyl (3S,4aR,10aR)-6-methoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylate | C16H21NO3 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(III)The methylation of 1,6-naphthalenediol (I) with dimethyl sulfate gives 1,6-dimethoxynaphthalene (II), which by reaction with sodium-ethanol is converted to 5-methoxy-2-tetralone (III). The condensation of (III) with propylamine - p-toluenesulfonic acid and subsequent hydrogenation with H2 over Pt affords 5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine (IV). which is demethylated with HBr to 5-hydroxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine (V). Finally, this compound is reductively alkytated with 2-thienylacetic acid (VI) using boranetrimethylamine complex to yield N-0437.
【1】 Seeman, P.; Horn, A.S.; Grigoriadis, D.; Watanabe, M.; van der Weide, J.; Tepper, P.; Synthesis and radioreceptor binding of N-0437, a n. Pharm Weekbl - Sci Ed 1984, 7, 208. |
【2】 Horn, A.S.; N-0437. Drugs Fut 1987, 12, 3, 220. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 22954 | 7,8-dihydro-1,6-naphthalenediol | C10H10O2 | 详情 | 详情 | |
(II) | 22955 | 5-methoxy-3,4-dihydro-2-naphthalenyl methyl ether; 3,8-dimethoxy-1,2-dihydronaphthalene | C12H14O2 | 详情 | 详情 | |
(III) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(IV) | 14648 | N-(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-propylamine; 5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine | C14H21NO | 详情 | 详情 | |
(V) | 22958 | 6-(propylamino)-5,6,7,8-tetrahydro-1-naphthalenol | C13H19NO | 详情 | 详情 | |
(VI) | 22959 | 2-(2-thienyl)acetic acid | 1918-77-0 | C6H6O2S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(III)The overall synthetic approach to N-0923 is described: Methylation of 1,6-dihydroxynaphthalene (I) with dimethyl sulfate provides 1,6-dimethoxynaphthalene (II), which is converted to 5-methoxy-2-tetralone (III) by reduction with sodium in ethanol. Reductive amination of (III) with propylamine results in the racemic 5-methoxy-2-N-propylaminotetralin (IV), from which the (-)-enantiomer (V) is obtained by fractional crystallization of the dibenzoyl-L-tartaric acid (L-DBTA) salt. Demethylation with aqueous hydrobromic acid affords (-)-(S)-5-hydroxy-2-N-propylaminotetralin (VI), which is reductively alkylated with thienylacetic acid in the presence of trimethylaminoborane to (-)-(S)-5-hydroxy-2-[N-propyl-N-[2-(2-thienyl)ethyl]amino]tetralin (VII). Treatment with anhydrous hydrogen chloride in ether provides N-0923.
【1】 Evans, D.; Grey, T.F.; Richards, K.E.; Ames, D.E.; Islip, P.J.; Synthesis of alkoxy-1,2,3,4-tetrahydronaphthalene derivatives. J Chem Soc 1965, 2636-41. |
【2】 Wynberg, H.; Ten Hoeve, W.; Ten Hoeve, W., Wynberg, H. The design of resolving agents. Chiral phosphoric acids. J Org Chem 1985, 50, 4508-14. |
【3】 Manimaran, T.; Impastato, F.J. (Ethyl Corporation); Resolution of racemic mixtures. US 4968837 . |
【4】 Cusack, N.J.; Peck, J.V.; N-0923. Drugs Fut 1993, 18, 11, 1005. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
22959 | 2-(2-thienyl)acetic acid | 1918-77-0 | C6H6O2S | 详情 | 详情 | |
(I) | 14645 | 1,6-naphthalenediol; 1,6-Dihydroxynaphthalene | 575-44-0 | C10H8O2 | 详情 | 详情 |
(II) | 14646 | 5-methoxy-2-naphthyl methyl ether; 1,6-dimethoxynaphthalene | 3900-49-0 | C12H12O2 | 详情 | 详情 |
(III) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(IV) | 14648 | N-(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-propylamine; 5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine | C14H21NO | 详情 | 详情 | |
(V) | 14649 | (2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine; N-[(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-N-propylamine | C14H21NO | 详情 | 详情 | |
(VI) | 14650 | (6S)-6-(propylamino)-5,6,7,8-tetrahydro-1-naphthalenol | C13H19NO | 详情 | 详情 | |
(VII) | 14651 | (6S)-6-[propyl[2-(2-thienyl)ethyl]amino]-5,6,7,8-tetrahydro-1-naphthalenol | C19H25NOS | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(I)Ketoester (II) was prepared by condensation of dimethyl carbonate with 5-methoxy-2-tetralone (I) in the presence of NaOMe. The alkylation of (II) with allyl bromide using two equivalents of LDA at -78 C proceeded selectively on the C-3 position to give (III). Further decarbomethoxylation of (III) was carried out with LiCl in moist DMSO at high temperature, and the resulting ketone (IV) was converted to ethylene ketal (V) with ethylene glycol and p-TsOH. Then, hydroboration of (V) with disiamyl borane (VI) in cold THF, followed by oxidation of borane (VII) with H2O2-NaOH furnished the primary alcohol (VIII). After Jones oxidation of alcohol (VIII), the resulting acid (IX) was esterified with MeOH and H2SO4 to give ketoester (X). Subsequent cyclization of (X) with benzylamine (XI) and AcOH in refluxing benzene afforded the intermediate tricyclic enamide (XII), which was sequentially reduced with LiAlH4 to enamine (XIII), and then with NaBH4 in the presence of AcOH to furnish a mixture of cis and trans octahydrobenzo[g]quinolines (XIV). Separation of the major trans isomer by flash chromatography was followed by hydrogenolysis of the benzyl group over Pd/C, yielding the secondary amine (XV), whitch was N-alkylated with propargyl bromide (XVI) in hot DMF to give (XVII).
【1】 Tagmatarchis, N.; Thermos, K.; Katerinopoulos, H.E.; N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: Synthesis and adrenergic and dopaminergic activity studies. J Med Chem 1998, 41, 21, 4165. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(II) | 20448 | methyl 5-methoxy-2-oxo-1,2,3,4-tetrahydro-1-naphthalenecarboxylate | C13H14O4 | 详情 | 详情 | |
(III) | 20449 | methyl 3-allyl-5-methoxy-2-oxo-1,2,3,4-tetrahydro-1-naphthalenecarboxylate | C16H18O4 | 详情 | 详情 | |
(IV) | 20450 | 3-allyl-5-methoxy-3,4-dihydro-2(1H)-naphthalenone | C14H16O2 | 详情 | 详情 | |
(V) | 20451 | 3'-Allyl-5'-methoxy-1',2',3',4'-tetrahydrospiro[1,3-dioxolan-2,2'-naphthalene] | C16H20O3 | 详情 | 详情 | |
(VI) | 20452 | bis(1,2-dimethylpropyl)borane | 132509-17-2 | C10H23B | 详情 | 详情 |
(VII) | 20453 | B-[3-[5'-Methoxy-1',2',3',4'-tetrahydrospiro[1,3-dioxolan-2,2'-naphthalen]-3'-yl]propyl]-B,B-bis(1,2-dimethylpropyl)borane | C26H43BO3 | 详情 | 详情 | |
(VIII) | 20454 | 3-[5'-Methoxy-1',2',3',4'-tetrahydrospiro[1,3-dioxolan-2,2'-naphthalen]-3'-yl]propan-1-ol | C16H22O4 | 详情 | 详情 | |
(IX) | 20455 | 3-(8-methoxy-3-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)propionic acid | C14H16O4 | 详情 | 详情 | |
(X) | 20456 | methyl 3-(8-methoxy-3-oxo-1,2,3,4-tetrahydro-2-naphthalenyl)propanoate | C15H18O4 | 详情 | 详情 | |
(XI) | 15147 | Benzylamine; Phenylmethanamine | 100-46-9 | C7H9N | 详情 | 详情 |
(XII) | 20458 | 1-benzyl-6-methoxy-3,4,4a,5-tetrahydrobenzo[g]quinolin-2(1H)-one | C21H21NO2 | 详情 | 详情 | |
(XIII) | 20459 | 1-benzyl-6-methoxy-1,2,3,4,4a,5-hexahydrobenzo[g]quinoline; 1-benzyl-1,2,3,4,4a,5-hexahydrobenzo[g]quinolin-6-yl methyl ether | C21H23NO | 详情 | 详情 | |
(XIV) | 20460 | 1-benzyl-6-methoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline; 1-benzyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl methyl ether | C21H25NO | 详情 | 详情 | |
(XV) | 20461 | (4aS,10aS)-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl methyl ether; (4aS,10aS)-6-methoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline | C14H19NO | 详情 | 详情 | |
(XVI) | 11176 | 3-Bromopropyne; 3-Bromo-1-propyne | 106-96-7 | C3H3Br | 详情 | 详情 |
(XVII) | 20463 | (4aS,10aS)-1-(2-propynyl)-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl methyl ether; (4aS,10aS)-6-methoxy-1-(2-propynyl)-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline | C17H21NO | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(I)
【1】 Aristoff PA. 1987. Interphenylene carbacyclin derivatives. US 4683330(本专利属于The Upjohn Compa- ny) Aristoff PA 1981.Composition and pro卧US 4306075(本专利■于The Upjohn Company) Aristoff PA. 1982,Methno carbacyclin analogs US 4349689(本专利属于The Upjohn Company) |
【2】 Aristoff PA. 1981.Composition and process. US 4306075(本专利属于The Upjohn Company) |
【3】 Aristoff PA. 1982. Methno carbacyclin analogs. US 4349689(本专利属于The Upjohn Company) |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(II) | 46567 | (3aS)-5-methoxy-3a,4-dihydronaphtho[2,3-b]furan-2(3H)-one | C13H12O3 | 详情 | 详情 | |
(III) | 46566 | dimethyl (4S)-4-(tetrahydro-2H-pyran-2-yloxy)nonylphosphonate | C16H33O5P | 详情 | 详情 | |
(IV) | 46568 | (9aS)-8-methoxy-3-[(3S)-3-(tetrahydro-2H-pyran-2-yloxy)octyl]-1,4,9,9a-tetrahydro-2H-cyclopenta[b]naphthalen-2-one | C27H38O4 | 详情 | 详情 | |
(VI) | 46549 | (2R,3R,4R)-2-(3-[[tert-butyl(dimethyl)silyl]oxy]benzyl)-4-(tetrahydro-2H-pyran-2-yloxy)-3-[(E,3S)-3-(tetrahydro-2H-pyran-2-yloxy)-1-octenyl]cyclopentanone | C36H58O6Si | 详情 | 详情 | |
(VII) | 66890 | 2-(3-((tert-butyldimethylsilyl)oxy)benzyl)-1-((N-methylphenylsulfonimidoyl)methyl)-4-((tetrahydro-2H-pyran-2-yl)peroxy)-3-(3-((tetrahydro-2H-pyran-2-yl)peroxy)octyl)cyclopentanol | C44H71NO9SSi | 详情 | 详情 | |
(VIII) | 46555 | [(1S,2S,3S,4R)-2-(3-hydroxybenzyl)-4-(tetrahydro-2H-pyran-2-yloxy)-3-[(E,3S)-3-(tetrahydro-2H-pyran-2-yloxy)-1-octenyl]cyclopentyl]methyl methanesulfonate | C32H50O8S | 详情 | 详情 | |
(IX) | 46556 | (1S,2R,3aS,9aS)-2-(tetrahydro-2H-pyran-2-yloxy)-1-[(E,3S)-3-(tetrahydro-2H-pyran-2-yloxy)-1-octenyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-5-ol | C31H46O5 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(I)
【1】 Horn AS.1986.Substituted 2-aminotetralins. US 4,564,628. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(II) | 67409 | 5-methoxy-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine | 102120-95-6 | C17H21NOS | 详情 | 详情 |
(III) | 67410 | N-(5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)-N-(2-(thiophen-2-yl)ethyl)propionamide | C20H25NO2S | 详情 | 详情 | |
(IV) | 67411 | 5-methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine | C20H27NOS | 详情 | 详情 |
合成路线7
该中间体在本合成路线中的序号:(I)
【1】 Hacksell U, Svensson U, Nilsson JLG.1979.N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity.J Med Chem, 22: 1469~1475. |
【2】 Marquillas Olondriz F, Pomares Marco M.2010.Process for the preparation of optically active (S)-(-)-2-(N-propylamino)-5-methoxytetraline and (S)-(-)-2-(N-propylamino)-5-hydroxytetraline compounds. WO 2010/043571 A1. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 14649 | (2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine; N-[(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-N-propylamine | C14H21NO | 详情 | 详情 | |
(I) | 14647 | 5-methoxy-3,4-dihydro-2(1H)-naphthalenone | 32940-15-1 | C11H12O2 | 详情 | 详情 |
(II) | 14648 | N-(5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)-N-propylamine; 5-methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine | C14H21NO | 详情 | 详情 | |
(III) | 67412 | (R)-2-(3,5-dinitrobenzamido)-2-phenylacetic acid | C15H11N3O7 | 详情 | 详情 | |
(IV) | 67413 | C14H21NO.C15H11N3O7 | 详情 | 详情 | ||
(VI) | 67414 | (R)-5-methoxy-N-propyl-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine | C20H27NOS | 详情 | 详情 |